Blood test may predict pancreatic cancer return after surgery
NCT ID NCT05479708
First seen Apr 17, 2026 · Last updated May 02, 2026 · Updated 4 times
Summary
This study looks at whether a blood test that finds tiny bits of tumor DNA (ctDNA) can spot leftover cancer cells after pancreatic cancer surgery. Researchers will follow 150 patients who had their tumor removed and are getting chemotherapy. The goal is to see if this test can predict who will have the cancer come back, which could help doctors decide on better treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER RESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Conditions
Explore the condition pages connected to this study.